SCHWARZ PHARMA, INC.
Patent Owner
Stats
- 1 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Sep 15, 1998 most recent publication
Details
- 1 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 193 Total Citation Count
- May 11, 1979 Earliest Filing
- 7 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
5807895 Use of prostaglandin E1, E2 or analogs to prevent renal failure induced by medical tests that utilize contrast media agentsExpiredNov 28, 95Sep 15, 98[A61K]
5276060 Methods of treating tumors with compositions of catecholic butanesExpiredApr 15, 91Jan 04, 94[A61K]
5008294 Methods of treating tumors with compositions of catecholic butanesExpiredJun 03, 87Apr 16, 91[A61K]
4310516 Cosmetic and pharmaceutical vehicle thickened with solid emulsifierExpiredFeb 01, 80Jan 12, 82[A61K]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.